Individualized treatment with sunitinib versus standard dosing with sunitinib or pazopanib in patients with metastatic renal cell carcinoma (mRCC): Results from the Canadian Kidney Cancer information system (CKCis).Naveen S. Basappa, Daniel Yick Chin Heng, Lori Wood et al.|Journal of Clinical Oncology|2017Cited by 6
Individualized treatment with sunitinib versus standard dosing with sunitinib or pazopanib in patients with metastatic renal cell carcinoma (mRCC): Results from the Canadian Kidney Cancer information system (CKCis).Naveen S. Basappa, Daniel Yick Chin Heng, Aly‐Khan A. Lalani et al.|Journal of Clinical Oncology|2017Cited by 0